|
|
|---|
|
|
|
|
|
|
5763. Bals-Pratsch M;
Bühler K;
Krüssel J;
Wendelken M;
Dahncke W;
Kupka MS
Extended Analyses of the German IVF Registry (DIR): Andrological Aspects, Medical-Economical Assumptions Related to the Shift from IVF to ICSI and Stimulation with Gonadotropins
IVF - ICSI
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 40-44
|
|
|
5764. Bals-Pratsch M;
Bühler K;
Krüssel J;
Wendelken M;
Dahncke W;
Kupka MS
Extended Analyses of the German IVF Registry (DIR): Andrological Aspects, Medical-Economical Assumptions Related to the Shift from IVF to ICSI and Stimulation with Gonadotropins
IVF - ICSI
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 40-44
Mean percentage rates (± 95 %-CI) of rFSH or hMG stimulated IVF or ICSI
cycles leading to oocyte retrieval in women > 34 years, 280,394 prospective cycles,
D.I.R 1998–2008. |
|
|
5765. Bals-Pratsch M;
Bühler K;
Krüssel J;
Wendelken M;
Dahncke W;
Kupka MS
Extended Analyses of the German IVF Registry (DIR): Andrological Aspects, Medical-Economical Assumptions Related to the Shift from IVF to ICSI and Stimulation with Gonadotropins
ART
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 40-44
Mean percentage rates (± 95 %-CI) of rFSH and hMG application for IVF or
ICSI treatment in relation to changes in the reimbursement of ART cycles by the public
health insurance, 280,394 prospective cycles, D.I.R 1998–2008. |
|
|
5766. Bals-Pratsch M;
Bühler K;
Krüssel J;
Wendelken M;
Dahncke W;
Kupka MS
Extended Analyses of the German IVF Registry (DIR): Andrological Aspects, Medical-Economical Assumptions Related to the Shift from IVF to ICSI and Stimulation with Gonadotropins
IVF - ICSI
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 40-44
Mean pregnancy rates (± 95 %-CI) for stimulated IVF or ICSI cycles with
recombinant FSH (rFSH) and urinary menotropin (hMG), 280,394 prospective cycles,
D.I.R, 1998–2008. |
|
|
5767. Bals-Pratsch M;
Bühler K;
Krüssel J;
Wendelken M;
Dahncke W;
Kupka MS
Extended Analyses of the German IVF Registry (DIR): Andrological Aspects, Medical-Economical Assumptions Related to the Shift from IVF to ICSI and Stimulation with Gonadotropins
IVF - ICSI
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 40-44
Means (± 95 %-CI) for number of oocytes retrieved (n = 4,610,133) in IVF
(line with circle) or ICSI (line with quad) cycles (1998–2008). |
|
|
5768. Bals-Pratsch M;
Bühler K;
Krüssel J;
Wendelken M;
Dahncke W;
Kupka MS
Extended Analyses of the German IVF Registry (DIR): Andrological Aspects, Medical-Economical Assumptions Related to the Shift from IVF to ICSI and Stimulation with Gonadotropins
ICSI
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 40-44
Percentage of ICSI cycles in private fertility centers (dashed line with triangle)
and public general or university hospitals (solid line with quad) (1998–2008). |
|
|
5769. Bals-Pratsch M;
Bühler K;
Krüssel J;
Wendelken M;
Dahncke W;
Kupka MS
Extended Analyses of the German IVF Registry (DIR): Andrological Aspects, Medical-Economical Assumptions Related to the Shift from IVF to ICSI and Stimulation with Gonadotropins
IVF - ICSI
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 40-44
Percentage of IVF (line with filled circle) and ICSI (line with filled quad) cycles
(n = 488,174) performed plotted against the female age (1998–2008), means for percentage
of IVF and ICSI treatments are marked by solid lines. |
|
|
5770. Bals-Pratsch M;
Bühler K;
Krüssel J;
Wendelken M;
Dahncke W;
Kupka MS
Extended Analyses of the German IVF Registry (DIR): Andrological Aspects, Medical-Economical Assumptions Related to the Shift from IVF to ICSI and Stimulation with Gonadotropins
IVF - ICSI
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 40-44
Percentage of IVF (line with filled circle) and ICSI (line with filled quad) cycles
(n = 488,174) performed plotted against the number of oocytes available for
fertilisation (1998–2008). |
|
|
5771. Bals-Pratsch M;
Bühler K;
Krüssel J;
Wendelken M;
Dahncke W;
Kupka MS
Extended Analyses of the German IVF Registry (DIR): Andrological Aspects, Medical-Economical Assumptions Related to the Shift from IVF to ICSI and Stimulation with Gonadotropins
IVF -ICSI
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 40-44
Percentage of fertilisation failure in IVF (line with filled circle) or ICSI cycles
(line with filled quad) plotted against the number of oocytes available for fertilisation
(1999–2001). |
|
|
5772. Bals-Pratsch M;
Bühler K;
Krüssel J;
Wendelken M;
Dahncke W;
Kupka MS
Extended Analyses of the German IVF Registry (DIR): Andrological Aspects, Medical-Economical Assumptions Related to the Shift from IVF to ICSI and Stimulation with Gonadotropins
ART
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 40-44
Annual development of ART cycles in Germany 1998–2008 (n = 498,784).
IVF/ICSI cycles are fresh cycles in which oocyctes are divided for both IVF and ICSI
treatment. |
|
|
5773. Bals-Pratsch M;
Bühler K;
Krüssel J;
Wendelken M;
Dahncke W;
Kupka MS
Extended Analyses of the German IVF Registry (DIR): Andrological Aspects, Medical-Economical Assumptions Related to the Shift from IVF to ICSI and Stimulation with Gonadotropins
ART
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 40-44
Annual pregnancy rates (%) for cryopreserved ejaculated sperm and fresh or
frozen testicular sperm (means ± 95 %-CI), p < 0.05 in 2002; 1998–2008 (total 25,740
ART cycles). |
|
|
5774. Bals-Pratsch M;
Bühler K;
Krüssel J;
Wendelken M;
Dahncke W;
Kupka MS
Extended Analyses of the German IVF Registry (DIR): Andrological Aspects, Medical-Economical Assumptions Related to the Shift from IVF to ICSI and Stimulation with Gonadotropins
ART
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 40-44
Means (± 95 %-confidence interval [CI]) for fertilization rate, pregnancy rate,
birth and miscarriage rate and singleton pregnancy rate for ejaculated, cryopreserved
or testicular sperm in percent (%), 293,312 ART cycles 1998–2008, lost for follow-up
13.7 %. |
|
|
5775. Bals-Pratsch M;
Bühler K;
Krüssel J;
Wendelken M;
Dahncke W;
Kupka MS
Extended Analyses of the German IVF Registry (DIR): Andrological Aspects, Medical-Economical Assumptions Related to the Shift from IVF to ICSI and Stimulation with Gonadotropins
ART
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 40-44
Increase in annual numbers for ART cycles with cryopreserved ejaculated
sperm or fresh or frozen testicular sperm (TESE/“cryo“-TESE) 1998–2008 (total 25,740
ART cycles). |
|
|
5776. Bals-Pratsch M;
Bühler K;
Krüssel J;
Wendelken M;
Dahncke W;
Kupka MS
Extended Analyses of the German IVF Registry (DIR): Andrological Aspects, Medical-Economical Assumptions Related to the Shift from IVF to ICSI and Stimulation with Gonadotropins
ART
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 40-44
Indications for ART-related diagnosis according to the kind of sperm retrieval
1998–2008 (302,413 ART cycles). |
|
|
5777. Kupka MS;
Bühler K;
Dahncke W;
Wendelken M;
Bals-Pratsch M
Summary of the 2008 Annual Report of the German IVF Registry
IVF - ICSI
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 34-38
Pregnancy outcomes in 2008 for single children
from IVF, ICSI and IVF/ICSI treatments as related
to gestation periods and birth weights. |
|
|
5778. Kupka MS;
Bühler K;
Dahncke W;
Wendelken M;
Bals-Pratsch M
Summary of the 2008 Annual Report of the German IVF Registry
IVF - ICSI
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 34-38
Progression of pregnancy rates for IVF, ICSI
and IVF/ICSI treatments as related to the number of treatment cycles over 10 years |
|
|
5779. Kupka MS;
Bühler K;
Dahncke W;
Wendelken M;
Bals-Pratsch M
Summary of the 2008 Annual Report of the German IVF Registry
ICSI
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 34-38
2008 results for ICSI treatment and miscarriage
rates by age group. Blue column: to overcome
geographical differences in reimbursement system or
the availability of professional services D·I·R has
generated some statistics for a so called “idealâ€
couple: 2 embryos transferred and at least 2 more
oocytes in the 2-PN-stage (cryo-preserved or destroyed). |
|
|
5780. Kupka MS;
Bühler K;
Dahncke W;
Wendelken M;
Bals-Pratsch M
Summary of the 2008 Annual Report of the German IVF Registry
Treatment types
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 34-38
2008 results as related to various treatment types “still not reportedâ€: normally, in the following year this rate drops to about 13 %. |
|
|
|
|
|
5782. Hiden U;
Desoye G
The Placenta in a Diabetic Pregnancy
Placental Phospholipid
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 27-33
Proportion (%) of long-chain polyunsaturated fatty acids arachidonic acid (20:4), eicosapentaenoic acid
(22:5), docosahexaenoic acid (22:6) in placental phospholipid (PL) fractions and in triglycerides (TG) in control and
GDM pregnancies. According to data from [98]. |
|
|
5783. Hiden U;
Desoye G
The Placenta in a Diabetic Pregnancy
Total MT1-MMP
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 27-33
Total placental MT1-MMP protein expression (given as arbitrary units, a.u.) correlates with daily insulin
dose (units) in first trimester T1DM. According to data from [17]. |
|
|
5784. Geisthövel F;
Wacker A;
Brabant G;
Botsch F;
Maechtel A;
Wetzka B;
Ochsner A
Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
Box plots
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 6-26
Box plots of serum lipids, the major secondary (facultative) variable, in all groups of patients with functional androgenization.
For legend see Figure 2. Dotted lines represent the respective cut-off values: triglycerides (150 mg/dL), high density lipoprotein (HDL)-cholesterol (50 mg/dL).
Statistically significant differences are:
Triglycerids:
FCA vs. III, IV 0.0021, 0.0301
FAS I vs. III, IV < 0.0001, 0.0161
FAS III vs. II, C 0.0014, 0.0003
HDL :
FAS I vs.II–IV 0.0306, < 0.0001, 0.0003
FAS III vs. FCA, C 0.0173, 0.0001
FAS IV vs. C 0.0030 |
|
|
5785. Geisthövel F;
Wacker A;
Brabant G;
Botsch F;
Maechtel A;
Wetzka B;
Ochsner A
Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
Box plots
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 6-26
Box plots of selected major primary (classifying) variables in all groups of patients with functional androgenization. Results of classification of functional androgenization
summarizing full-blown and minimum standard core/miscellanous clusters (subgroups a and b, respectively). Statistically significant differences among the groups are shown
in detail in Table 8.
FCA: functional cutaneous androgenization; FAS: functional androgenizing syndrome. Insulin 1: 1-h post-load insulin. Results are shown as median (line within in the box), mean
(dot within the box), 75th and 25th percentiles (upper and lower limits of the box), maximum observation below upper fence ( ), minimum observation above lower fence (⊥) and
maximum observation (□). Dotted lines represent the respective cut-off values: LH (8.4 mIU/mL), testosterone (2.1 nmol/L), free androgen index (5), serum insulin 1 (723 pmol/
L). |
|
|
5786. Geisthövel F;
Wacker A;
Brabant G;
Botsch F;
Maechtel A;
Wetzka B;
Ochsner A
Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
Female androgenization
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2010; 7 (1): 6-26
Nomenclature and algorithm of classification of female androgenization. Diagnostic level I is the screening
step regarding clarification of functional androgenization (FA), and/or of cycle irregularities, and/or of infertility, particularly
in the combination with obesity (especially in adolescence). If e.g. elevated C19-sex steroid levels or low
SHBG levels are found, diagnostic level II (see Material and Methods) will follow. At least on this step, areas A to C
can be differentiated. In most cases, area A, the FA, will come in consideration. This area can be further divided
through step II into groups FCA (skin) and FAS I (ovary), II (adrenal gland), III (multi-organ FA disordes), and IV (residual
FA dysfunctions/disorders) (see Material and Methods). When very high serum levels of testosterone and/or DEHAS
are found, the dexamethasone test (level III) may be used in order to differentiate a functional adrenal hyperandrogenaemia
(FAS II) from a non-functional androgen excess which might suscpicous for a tumerous androgenization
(Area B) (data not shown). In addition, it has to be clarified on level II (e.g. by pathologic 17-hydroxy progesterone
levels), whether a CYP21A analysis should follow (level III). On the other hand, by an accurate enquiry concerning the
use of medicine just at the beginning of the medical care it will be found out whether area C (pharmaceutical androgenization)
has to be considered.
PFOs: polyfollicular ovaries; DHEAS: dehydroepiandrosterone-sulphate; SHBG: sex hormone-binding globulin; A:
functional androgenization; B: tumorous androgenization; C: pharmacological androgenization; FCA: functional cutaneous
androgenization; FAS: functional androgenizing syndrome. |
|
|
5787. Weißbach L;
Dylus J
Aktuelles: HAROW: Versorgungsforschung bei Patienten mit lokal begrenztem Prostatakarzinom
HAROW
Blickpunkt der Mann 2010; 8 (1): 41-42
Verteilung der Patienten nach Therapie Keywords: Andrologie
|
|
|
5788. Kappler D;
Holtmannspötter C;
Kobalz L;
Weib P
Fallbericht: Akute radikale und plastische Chirurgie im Falle einer ausgedehnten Fournier'schen Gangrän
Fournier'sche Gangrän
Blickpunkt der Mann 2010; 8 (1): 37-39
Nach Anhebung der Penisbasis, Skrotumrekonstruktion und Protheseninsertion Keywords: Andrologie,
Foto,
Fourniersche Gangrän
|
|
|
5789. Kappler D;
Holtmannspötter C;
Kobalz L;
Weib P
Fallbericht: Akute radikale und plastische Chirurgie im Falle einer ausgedehnten Fournier'schen Gangrän
Fournier'sche Gangrän
Blickpunkt der Mann 2010; 8 (1): 37-39
Befund vor endgültiger Genitalrekonstruktion Keywords: Andrologie,
Foto,
Fourniersche Gangrän
|
|
|
5790. Kappler D;
Holtmannspötter C;
Kobalz L;
Weib P
Fallbericht: Akute radikale und plastische Chirurgie im Falle einer ausgedehnten Fournier'schen Gangrän
Fournier'sche Gangrän
Blickpunkt der Mann 2010; 8 (1): 37-39
Nach Implantation des Skinexpanders Keywords: Andrologie,
Foto,
Fourniersche Gangrän
|
|
|
5791. Kappler D;
Holtmannspötter C;
Kobalz L;
Weib P
Fallbericht: Akute radikale und plastische Chirurgie im Falle einer ausgedehnten Fournier'schen Gangrän
Fournier'sche Gangrän
Blickpunkt der Mann 2010; 8 (1): 37-39
Gute Wundverhältnisse nach Meshgrafttransplantat Keywords: Andrologie,
Foto,
Fourniersche Gangrän
|
|
|
5792. Kappler D;
Holtmannspötter C;
Kobalz L;
Weib P
Fallbericht: Akute radikale und plastische Chirurgie im Falle einer ausgedehnten Fournier'schen Gangrän
Fournier'sche Gangrän
Blickpunkt der Mann 2010; 8 (1): 37-39
Primäre Schwenklappenplastik und Meshgraftdeckung des Penisschaftes Keywords: Andrologie,
Foto,
Fourniersche Gangrän
|
|
|
5793. Kappler D;
Holtmannspötter C;
Kobalz L;
Weib P
Fallbericht: Akute radikale und plastische Chirurgie im Falle einer ausgedehnten Fournier'schen Gangrän
Fournier'sche Gangrän
Blickpunkt der Mann 2010; 8 (1): 37-39
Befund nach Penis- und Hodenverlagerung Keywords: Andrologie,
Foto,
Fourniersche Gangrän
|
|
|
5794. Kappler D;
Holtmannspötter C;
Kobalz L;
Weib P
Fallbericht: Akute radikale und plastische Chirurgie im Falle einer ausgedehnten Fournier'schen Gangrän
Fournier'sche Gangrän
Blickpunkt der Mann 2010; 8 (1): 37-39
Erster postoperativer Tag Keywords: Andrologie,
Foto,
Fourniersche Gangrän
|
|
|
5795. Sommer F;
Gerwe M
Behandlungsoptionen der Ejaculatio praecox: Schwerpunkt auf Dapoxetin
Ejaculatio praecox
Blickpunkt der Mann 2010; 8 (1): 29-36
Zufriedenheit mit dem Geschlechtsverkehr (Anteil mit Verbesserung
von ≥ 1-Kategorie, Woche 12) (* p < 0,001 vs. Placebo CMH; †p < 0,01 vs. Placebo
CMH). Woche 12 (NCT00211094, NCT00211107, NCT00229073, NCT00210704) oder
der letzte beobachtete Wert (LOCF) [68, 69]. CMH: Cochran-Mantel-Haenszel-Test Keywords: Andrologie,
Diagramm,
EP
|
|
|
5796. Sommer F;
Gerwe M
Behandlungsoptionen der Ejaculatio praecox: Schwerpunkt auf Dapoxetin
Ejaculatio praecox
Blickpunkt der Mann 2010; 8 (1): 29-36
Kontrolle über die Ejakulation, Anteil mit ≥ 1-Kategoie, Woche 12 (†Woche
12 [NCT00211094, NCT00211107, NCT00229073, NCT00210704] oder der letzte beobachtete
Wert [LOCF] [67–70]) (*p < 0,001 vs. Placebo, †p < 0,01 vs. Placebo) Keywords: Andrologie,
Diagramm,
EP
|
|
|
5797. Sommer F;
Gerwe M
Behandlungsoptionen der Ejaculatio praecox: Schwerpunkt auf Dapoxetin
Ejaculation praecox
Blickpunkt der Mann 2010; 8 (1): 29-36
PE-bezogener persönlicher Leidensdruck (Anteil mit ≥ 1-Kategorie bezüglich
der Ejakulation in Woche 12, * p < 0,001 vs. Placebo, †p < 0,01 vs. Placebo).
Woche 12 (gepoolt, NCT00229073, NCT00210704) oder der letzte beobachtete Wert
(LOCF) [67–70]. Keywords: Andrologie,
Diagramm,
PE
|
|
|
5798. Sommer F;
Gerwe M
Behandlungsoptionen der Ejaculatio praecox: Schwerpunkt auf Dapoxetin
Ejaculation praecox
Blickpunkt der Mann 2010; 8 (1): 29-36
Durchschnittliche IELT nach Studien und Behandlung zum Endpunkt
(Woche 12 [gepoolt, NCT00211094, NCT00211107, NCT00210704] oder Woche 24
[NCT00229073] oder der letzte beobachtete Wert [LOCF] [67–70]) (*p < 0,001 vs. Placebo
ANCOVA). Keywords: Andrologie,
Diagramm,
IELT
|
|
|
5799. Bolbach U;
Püttmann P;
Brinkmann R;
Wagener B;
Garmer M;
Busch M;
Orth SR;
Grönemeyer D;
Truß MC
MRT-gesteuerte Prostatastanzbiopsie: Eine innovative diagnostische Option
MRT
Blickpunkt der Mann 2010; 8 (1): 10-13
Kontrolle und Dokumentation der Nadel im Zielgebiet Keywords: Andrologie,
MRT
|
|
|
5800. Bolbach U;
Püttmann P;
Brinkmann R;
Wagener B;
Garmer M;
Busch M;
Orth SR;
Grönemeyer D;
Truß MC
MRT-gesteuerte Prostatastanzbiopsie: Eine innovative diagnostische Option
MRT
Blickpunkt der Mann 2010; 8 (1): 10-13
Ansteuern des tumorsuspekten Areals Keywords: Andrologie,
MRT
|
|
|
| |
Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Fachbücher
Patientenliteratur
